Medical Marijuana Research Act of 2017

Generic 17 August 2017 | 0 Comments

Representatives Andy Harris, M.D. (R-MD-01), Earl Blumenauer (D-OR-03), H. Morgan Griffith (R-VA-09), and Zoe Lofgren (D-CA-19) introduced H.R. 3391: The Medical Marijuana Research Act of 2017. This Act amends the federal law to facilitate clinical investigations involving the use of cannabis and cannabis-derived products. As you may know, there are many benefits to medical cannabis. [...]

Tagged in ,

DEA Reaffirms Stance That CBD Meets Schedule I Criteria — Reality Says Otherwise

Generic 11 July 2017 | 0 Comments

The US Drug Enforcement Administration has publicly reiterated its position that cannabidiol, a non-psychotropic cannabinoid, is properly categorized under federal law as a schedule I controlled substance — meaning that, by definition, it possesses “a high potential for abuse,” “no currently accepted medical use in treatment in the United States,” and lacks “accepted safety … [...]

Tagged in , , ,

Review Identifies 140 Controlled Clinical Trials Related to Cannabis

Generic 4 June 2017 | 0 Comments

Scientists have conducted over 140 controlled clinical trials since 1975 assessing the safety and efficacy of whole-plant cannabis or specific cannabinoids, according to a new literature review published in the journal Critical Reviews in Plant Sciences. A team of German researchers identified 140 clinical trials involving an estimated 8,000 participants. Of these, the largest body [...]

Tagged in ,

DEA Reaffirms ‘Flat Earth’ Position With Regard To Scheduling Marijuana

Generic 12 August 2016 | 0 Comments

The United States Drug Enforcement Administration has rejected a pair of administrative petitions that sought to initiate rulemaking proceedings to reschedule marijuana under federal law. Although the DEA’s ruling continues to classify marijuana in the same category as heroin, the agency also announced in a separate decision that it is adopting policy changes designed to [...]

Tagged in , , ,

DEA Reaffirms ‘Flat Earth’ Position With Regard To Marijuana Scheduling

Generic 11 August 2016 | 0 Comments

The United States Drug Enforcement Administration has decided to reject a pair of administrative rescheduling petitions challenging the federal classification of cannabis as a Schedule I controlled substance with no accepted medical utility, according to advanced news reports published this evening by NPR, the New York Times, Reuters, and other news outlets. The DEA is [...]

Tagged in , , ,